Biomedical Neuroscience Institute, Faculty of Medicine, University of Chile, Santiago, Chile.
Cell Death Dis. 2012 Feb 16;3(2):e272. doi: 10.1038/cddis.2012.8.
Spinal cord injury (SCI) is a major cause of paralysis, and involves multiple cellular and tissular responses including demyelination, inflammation, cell death and axonal degeneration. Recent evidence suggests that perturbation on the homeostasis of the endoplasmic reticulum (ER) is observed in different SCI models; however, the functional contribution of this pathway to this pathology is not known. Here we demonstrate that SCI triggers a fast ER stress reaction (1-3 h) involving the upregulation of key components of the unfolded protein response (UPR), a process that propagates through the spinal cord. Ablation of X-box-binding protein 1 (XBP1) or activating transcription factor 4 (ATF4) expression, two major UPR transcription factors, leads to a reduced locomotor recovery after experimental SCI. The effects of UPR inactivation were associated with a significant increase in the number of damaged axons and reduced amount of oligodendrocytes surrounding the injury zone. In addition, altered microglial activation and pro-inflammatory cytokine expression were observed in ATF4 deficient mice after SCI. Local expression of active XBP1 into the spinal cord using adeno-associated viruses enhanced locomotor recovery after SCI, and was associated with an increased number of oligodendrocytes. Altogether, our results demonstrate a functional role of the UPR in SCI, offering novel therapeutic targets to treat this invalidating condition.
脊髓损伤(SCI)是导致瘫痪的主要原因,涉及包括脱髓鞘、炎症、细胞死亡和轴突退化在内的多种细胞和组织反应。最近的证据表明,内质网(ER)稳态的失调在不同的 SCI 模型中都有观察到;然而,该通路对这种病理的功能贡献尚不清楚。在这里,我们证明 SCI 会引发快速的内质网应激反应(1-3 小时),涉及未折叠蛋白反应(UPR)关键组成部分的上调,这一过程会在脊髓中传播。X 盒结合蛋白 1(XBP1)或激活转录因子 4(ATF4)表达的缺失,这两种主要的 UPR 转录因子,会导致实验性 SCI 后的运动功能恢复减少。UPR 失活的影响与损伤区域周围受损轴突数量的显著增加和少突胶质细胞数量的减少有关。此外,在 SCI 后,ATF4 缺陷小鼠中观察到小胶质细胞激活和促炎细胞因子表达的改变。使用腺相关病毒将活性 XBP1 局部表达到脊髓中,可增强 SCI 后的运动功能恢复,并与更多的少突胶质细胞数量增加有关。总之,我们的研究结果表明 UPR 在 SCI 中具有功能作用,为治疗这种使人丧失能力的疾病提供了新的治疗靶点。